📰 Mark Swindells News
Mark Swindells News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Swindells. Real-time updates on events, politics, business and more.
September 26, 2023
There are actions you can take if you are assaulted at work, Abi Rimmer hears Becky Cox, co-founder of Surviving in Scrubs, says, “There is no right or wrong way to feel after being sexually assaulted. It’s normal to feel a range of emotions from anxiety to anger—even numbness. Working as doctors we anticipate the stress of long hours and high workloads, but we always expect to feel safe at work and never think we’ll be assaulted by a colleague. “When that safety is taken away healthca...
April 8, 2022
A senior GP who stole more than £1m of NHS money to fund his ‘desperate’ addiction to online gambling has been struck off.
April 7, 2022
Dr Rumi Chhapia embezzled £1.13 million from a Portsmouth healthcare group he co-founded as he chased the jackpot on internet slot machines and roulette to pay off his debts.
November 5, 2021
Dr Rumi Chhapia sentenced to three years and four months in prison after admitting fraud
May 19, 2021
Investegate announcements from Frontier IP Group, Exscientia collaboration with Bristol Myers Squibb
April 27, 2021
Exscientia Announces Investment of up to $525M Proceeds to continue expansion of proprietary pipeline and end-to-end AI drug discovery capabilities $225 million Series D round closed with access up to an additional $300 million at Exscientias discretion Financing led by SoftBank Vision Fund 2 Exscientia, a clinical stage pharmatech company using artificial intelligence (AI) to design patient-based drugs, announced that it has completed a $225 million Series D funding round. SoftBank Vision Fund...
February 11, 2021
Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimers disease Neuroinflammation collaboration targeting inflammasome steps-up-the-pace in race for Alzheimers disease medicines that alleviate the burden of devastating disease Exscientia, a leading AI Drug Discovery company, has today announced its collaboration with the Alzheimers Research UK University of Oxford Drug Discovery Institute (ARUK-ODDI) to develop medicines targeting neuroinflammation for...